Why packed red blood cells

Red blood cells do not provide viable platelets, nor do they provide clinically significant amounts of coagulation factors. In the additive solutions, refrigerated RBCs have a storage shelf life of 42 days.

Leukoreduction Indications Prevention of recurrent febrile non-hemolytic transfusion reactions Prevention of the transmission of CMV Prevention of alloimmunization to donor HLA antigens i. Patients with hematologic malignancies, some solid tumors incl. Prevention of anaphylactic transfusion reactions includes avoiding plasma transfusions with IgA in patients known to be IgA deficient.

Cellular products e. Transfusion-related acute lung injury TRALI is noncardiogenic pulmonary edema causing acute hypoxemia that occurs within six hours of a transfusion and has a clear temporal relationship to the transfusion.

Antineutrophil cytoplasmic antibodies or anti-HLA antibodies activate the recipient's immune system, resulting in massive pulmonary edema. Donor products that contain large amounts of plasma from multiparous women are associated with TRALI. Mortality in the United Kingdom decreased significantly after donor plasma from men was used exclusively.

Two mechanisms have been proposed to explain FNHTRs: a release of antibody-mediated endogenous pyrogen, and a release of cytokines. Common cytokines that may be associated with FNHTRs include interleukin-1, interleukin-6, interleukin-8, and tumor necrosis factor. Transfusion-associated circulatory overload is the result of a rapid transfusion of a blood volume that is more than what the recipient's circulatory system can handle. It is not associated with an antibody-mediated reaction.

Those at highest risk are recipients with underlying cardiopulmonary compromise, renal failure, or chronic anemia, and infants or older patients. Cardiomegaly and pulmonary edema are often seen on chest radiography. The diagnosis is made clinically, but may be assisted by measuring brain natriuretic peptide levels, which are elevated in response to an increase in filling pressure.

Transfusion-associated graft-versus-host disease is a consequence of a donor's lymphocytes proliferating and causing an immune attack against the recipient's tissues and organs.

It is fatal in more than 90 percent of cases. Risk factors include a history of fludarabine Oforta treatment, Hodgkin disease, stem cell transplant, intensive chemotherapy, intrauterine transfusion, or erythroblastosis fetalis. Other probable risk factors include a history of solid tumors treated with cytotoxic drugs, transfusion in premature infants, and recipient-donor pairs from homogenous populations. Already a member or subscriber?

Log in. Interested in AAFP membership? Learn more. LISA N. Reprints are not available from the authors. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. Transfusion strategies for patients in pediatric intensive care units. King KE, Bandarenko N. Bethesda, Md. Red blood cell transfusion in clinical practice. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline.

Ann Thorac Surg. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev.

Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol. Recommendations for the transfusion of plasma and platelets. Blood Transfus. Guidelines for the use of platelet transfusions.

Br J Haematol. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. Platelets, frozen plasma, and cryoprecipitate: what is the clinical evidence for their use in the neonatal intensive care unit? Semin Perinatol. Slichter SJ. Platelet transfusion therapy. Hematol Oncol Clin North Am. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia.

Cryoprecipitate: the current state of knowledge. Transfus Med Rev. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Investigation of whether the acute hemolysis associated with Rh o D immune globulin intravenous human administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model.

Lichtiger B, Perry-Thornton E. Hemolytic transfusion reactions in oncology patients: experience in a large cancer center. Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytopenic purpura. J Clin Apher. Transfusion reactions associated with anti-IgA antibodies: report of four cases and review of the literature. Transfusion-related acute lung injury and transfusion-associated circulatory overload: mutually exclusive or coexisting entities?

Vox Sang. Stack G, Tormey CA. The association of cytokine gene polymorphisms with febrile non-hemolytic transfusion reaction in multitransfused patients. Transfus Med. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Popovsky MA. Transfusion-associated circulatory overload: the plot thickens. Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload.

Webb I, Anderson KC. In: Anderson KC, ed. Philadelphia, Pa. This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference.

This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.

Contact afpserv aafp. Want to use this article elsewhere? Get Permissions. To determine if a blood transfusion should be given, a blood test called a complete blood count CBC is done. A person who needs red blood cells often feels weak and may feel out of breath with minimal activity. Prior to a needed transfusion, a patient may appear pale and feel fatigued. Whole blood is not typically transfused, instead, the component the patient needs is given.

The patient may receive plasma, or packed red blood cells, or if there is a need both may be given. After donated blood is collected, the components are separated in a centrifuge, then a small amount of an anticoagulant is added to keep the packed red blood cells from clotting. The blood is kept in a refrigerator and is good for approximately 42 days from the date of donation.

PRBCs must be matched to the recipient , meaning that the blood type of the donor and the recipient must be compatible. If the blood is not properly matched, the result can be a life-threatening reaction, so the match is typically double checked by lab staff and nursing staff at the minimum. Approximately 1 in 8 hospitalized patients needs a transfusion.

Some patients prefer to avoid a transfusion when possible or have religious beliefs that forbid transfusions. For this reason, bloodless surgery, a group of techniques that help patients avoid or minimize the need for blood is often performed for these patients.

Extensive testing is done to prevent tainted blood from reaching the blood supply. An initial screening is done to make sure the donor has no medical conditions or high-risk behaviors that make blood donation unwise. The donor is also screened for current illnesses, such as having a cold or the flu or having an infection a risk for spreading an infection to the recipient.

Once the blood has been collected, it is tested for infectious diseases, including hepatitis and HIV. The blood supply in the United States is among the safest in the world, however, if you are in a country outside of the U. Abroad, you may have difficulty obtaining a blood transfusion limited supply , the supply may not be considered safe, or testing may not be adequate.

The number of units given in a transfusion can range anywhere from one unit for someone who is anemic, to forty or fifty for a critically ill patient who is hemorrhaging and will die without blood immediately. While it is true that donors are not compensated for donating their blood, aside from a token gift or a snack, blood is still quite costly. These fees help pay for the staff that runs blood drives, the laboratory that processes the blood, transportation costs, blood bank technologists who match and issue the blood, and the nursing staff that gives the blood.

Sign up for our Health Tip of the Day newsletter, and receive daily tips that will help you live your healthiest life. Transfusion of blood and blood products: indications and complications.